Literature DB >> 20161173

Clinical Issues in the Pediatric Hypertrophic Cardiomyopathies.

Steven D Colan1.   

Abstract

Entities:  

Year:  2009        PMID： 20161173      PMCID： PMC2723819          DOI： 10.1016/j.ppedcard.2007.11.004

Source DB:  PubMed          Journal:  Prog Pediatr Cardiol        ISSN： 1058-9813


× No keyword cloud information.
  11 in total

1.  A novel TPM1 mutation in a family with hypertrophic cardiomyopathy and sudden cardiac death in childhood.

Authors:  Sara L Van Driest; Melissa L Will; Dianne L Atkins; Michael J Ackerman
Journal:  Am J Cardiol       Date:  2002-11-15       Impact factor: 2.778

2.  Cardiovascular trials in long-term survivors of childhood cancer.

Authors:  Steven E Lipshultz; Steven D Colan
Journal:  J Clin Oncol       Date:  2004-03-01       Impact factor: 44.544

3.  Are longitudinal, natural history studies the next step in genotype-phenotype translational genomics in hypertrophic cardiomyopathy?

Authors:  Michael J Ackerman; Sara L Van Driest; Martijn Bos
Journal:  J Am Coll Cardiol       Date:  2005-10-10       Impact factor: 24.094

4.  Sarcomeric genotyping in hypertrophic cardiomyopathy.

Authors:  Sara L Van Driest; Steve R Ommen; A Jamil Tajik; Bernard J Gersh; Michael J Ackerman
Journal:  Mayo Clin Proc       Date:  2005-04       Impact factor: 7.616

5.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

6.  Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.

Authors:  B J Maron; I Olivotto; P Spirito; S A Casey; P Bellone; T E Gohman; K J Graham; D A Burton; F Cecchi
Journal:  Circulation       Date:  2000-08-22       Impact factor: 29.690

7.  Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry.

Authors:  Steven D Colan; Steven E Lipshultz; April M Lowe; Lynn A Sleeper; Jane Messere; Gerald F Cox; Paul R Lurie; E John Orav; Jeffrey A Towbin
Journal:  Circulation       Date:  2007-01-29       Impact factor: 29.690

8.  Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines.

Authors:  Jeffrey H Silber; Avital Cnaan; Bernard J Clark; Stephen M Paridon; Alvin J Chin; Jack Rychik; Alexa N Hogarty; Mitchell I Cohen; Gerald Barber; Monika Rutkowski; Thomas R Kimball; Cynthia Delaat; Laurel J Steinherz; Huaqing Zhao
Journal:  J Clin Oncol       Date:  2004-03-01       Impact factor: 44.544

Review 9.  Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing.

Authors:  Matthew R G Taylor; Elisa Carniel; Luisa Mestroni
Journal:  Expert Rev Mol Diagn       Date:  2004-01       Impact factor: 5.225

Review 10.  Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases.

Authors:  Barry J Maron; Bernard R Chaitman; Michael J Ackerman; Antonio Bayés de Luna; Domenico Corrado; Jane E Crosson; Barbara J Deal; David J Driscoll; N A Mark Estes; Claudio Gil S Araújo; David H Liang; Matthew J Mitten; Robert J Myerburg; Antonio Pelliccia; Paul D Thompson; Jeffrey A Towbin; Steven P Van Camp
Journal:  Circulation       Date:  2004-06-08       Impact factor: 29.690
View more
  2 in total

Review 1.  The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years.

Authors:  James D Wilkinson; David C Landy; Steven D Colan; Jeffrey A Towbin; Lynn A Sleeper; E John Orav; Gerald F Cox; Charles E Canter; Daphne T Hsu; Steven A Webber; Steven E Lipshultz
Journal:  Heart Fail Clin       Date:  2010-10       Impact factor: 3.179

Review 2.  Importance of genetic evaluation and testing in pediatric cardiomyopathy.

Authors:  Muhammad Tariq; Stephanie M Ware
Journal:  World J Cardiol       Date:  2014-11-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.